On the upside
Smart Modular Technologies (Nasdaq: SMOD) reversed year ago losses to post a better than expected profit for the second quarter as revenue surged.
ARCA biopharma (Nasdaq: ABIO) was granted a patent for methods of treating heart failure patients with bucindolol based on genetic testing.
